Evolutionary History and Global Spread of the Emerging G12 Human RotavirusesMustafizur Rahman, Marc Van Ranst, Jelle Matthijnssens et al.|Journal of Virology|2006Cited by 318
Global SARS-CoV-2 seroprevalence from January 2020 to April 2022: A systematic review and meta-analysis of standardized population-based studiesIsabel Bergeri, Mairead Whelan, Lorenzo Subissi et al.|PLoS Medicine|2022Cited by 298
Prevalence of G2P[4] and G12P[6] Rotavirus, BangladeshMustafizur Rahman, Tasnim Azim, Rasheda Sultana et al.|Emerging infectious diseases|2007Cited by 186
Efficacy of oseltamivir treatment started within 5 days of symptom onset to reduce influenza illness duration and virus shedding in an urban setting in Bangladesh: a randomised placebo-controlled trialAlicia M. Fry, W. Abdullah Brooks, Joseph Bresee et al.|The Lancet Infectious Diseases|2013Cited by 142
Characterization of a Novel P[25],G11 Human Group A RotavirusMustafizur Rahman, Marc Van Ranst, Jelle Matthijnssens et al.|Journal of Clinical Microbiology|2005Cited by 133